Thermodynamics and kinetics of inhibitor binding to human equilibrative nucleoside transporter subtype-1
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 98 (4) , 681-689
Abstract
No abstract availableKeywords
Funding Information
- Biocenter Oulu/University of Oulu
- Research Council of Finland (132138)
- Sigrid Juselius Foundation
- FP7 Marie Curie European Reintegration Grant (249081)
This publication has 35 references indexed in Scilit:
- Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesNature Reviews Drug Discovery, 2013
- Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 ÅNature, 2012
- Equilibrative nucleoside transporter 1 plays an essential role in cardioprotectionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Kinetic and Thermodynamic Assessment of Binding of Serotonin Transporter InhibitorsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- The Thermodynamics of Protein–Ligand Interaction and Solvation: Insights for Ligand DesignJournal of Molecular Biology, 2008
- Thermodynamic analysis of ligands at cholecystokinin CCK2receptors in rat cerebral cortexBritish Journal of Pharmacology, 2007
- Compensating Enthalpic and Entropic Changes Hinder Binding Affinity OptimizationChemical Biology & Drug Design, 2007
- The structural stability of the HIV-1 protease 1 1Edited by P. E. WrightJournal of Molecular Biology, 1998
- Nucleoside and nucleobase transport systems of mammalian cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1996
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973